首页 > 最新文献

Northern clinics of Istanbul最新文献

英文 中文
Restrictive effects of thalassemia on respiratory functions: One center experience. 地中海贫血对呼吸功能的限制性影响:一个中心的经验。
Pub Date : 2023-09-14 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.65768
Gizem Zengin Ersoy, Ercan Nain, Mehtap Ertekin, Ozlem Terzi, Ayse Senay Sasihuseyinoglu, Gurcan Dikme

Objective: Respiratory functions in thalassemia major (TM) patients concerning poor chelation are a frequently researched issue. Our study aims to evaluate the lung functions of our patients with TM in the chronic transfusion program and to correlate them with their age, ferritin levels, and pre-transfusion hemoglobin values.

Methods: Height, weight, pulmonary function test (PFT) results, pre-transfusion hemoglobin levels, and ferritin levels of 97 patients (55 boys and 42 girls) without any underlying cardiac or chronic respiratory disease were recorded. PFT is consisted of forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), the ratio of FEV1/FVC to peak expiratory flow (PEF), and forced mid-exhaled flow between 25% and 75% of mid-expiratory flow (MEF25-75). Data were analyzed with IBM SPSS V25.

Results: Low FVC was observed in 58 patients (60%), and low FEV1 was observed in 26 patients (27.6%). Low PEF was observed in 62 patients (64.5%), and low MEF25-75 was observed in 8 (8.3%). PFT was affected in 75 patients (78.1%). The pattern of involvement was restrictive. Age, height, and ferritin values significantly affected the MEF25-75 (p<0.05). Age and pre-transfusion hemoglobin values had a significant effect on the FVC test (p<0.05). There was a weak negative correlation between ferritin values and MEF25-75 (r=-0.221) and a weak positive correlation between pre-transfusion hemoglobin and FVC (r=0.222).

Conclusion: Age and height are the main risk factors affecting FEV1, MEF25-75, and PEF. Serum ferritin has only an effect on MEF25-75 in our study. The respiratory functions of TM patients were affected in a restrictive pattern.

目的:重型地中海贫血(TM)患者的呼吸功能与螯合作用差是一个经常研究的问题。我们的研究旨在评估慢性输血项目中TM患者的肺功能,并将其与年龄、铁蛋白水平和输血前血红蛋白值相关联。方法:记录97名没有任何潜在心脏或慢性呼吸系统疾病的患者(55名男孩和42名女孩)的身高、体重、肺功能测试(PFT)结果、输血前血红蛋白水平和铁蛋白水平。PFT由用力肺活量(FVC)和1秒用力呼气量(FEV1)、FEV1/FVC与呼气峰流量(PEF)的比率以及呼气中流量的25%至75%之间的用力呼气中流量(MEF25-75)组成。结果:58例(60%)患者出现FVC低,26例(27.6%)患者出现FEV1低,62例(64.5%)患者出现PEF低,8例(8.3%)患者出现MEF25-75低。年龄、身高和铁蛋白值显著影响MEF25-75(p25-75(r=-0.221)),输血前血红蛋白与FVC呈弱正相关(r=0.222)。结论:年龄和身高是影响FEV1、MEF25-75%和PEF的主要危险因素。在我们的研究中,血清铁蛋白仅对MEF25-75有影响。TM患者的呼吸功能受到限制性影响。
{"title":"Restrictive effects of thalassemia on respiratory functions: One center experience.","authors":"Gizem Zengin Ersoy,&nbsp;Ercan Nain,&nbsp;Mehtap Ertekin,&nbsp;Ozlem Terzi,&nbsp;Ayse Senay Sasihuseyinoglu,&nbsp;Gurcan Dikme","doi":"10.14744/nci.2023.65768","DOIUrl":"10.14744/nci.2023.65768","url":null,"abstract":"<p><strong>Objective: </strong>Respiratory functions in thalassemia major (TM) patients concerning poor chelation are a frequently researched issue. Our study aims to evaluate the lung functions of our patients with TM in the chronic transfusion program and to correlate them with their age, ferritin levels, and pre-transfusion hemoglobin values.</p><p><strong>Methods: </strong>Height, weight, pulmonary function test (PFT) results, pre-transfusion hemoglobin levels, and ferritin levels of 97 patients (55 boys and 42 girls) without any underlying cardiac or chronic respiratory disease were recorded. PFT is consisted of forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), the ratio of FEV1/FVC to peak expiratory flow (PEF), and forced mid-exhaled flow between 25% and 75% of mid-expiratory flow (MEF<sub>25-75</sub>). Data were analyzed with IBM SPSS V25.</p><p><strong>Results: </strong>Low FVC was observed in 58 patients (60%), and low FEV1 was observed in 26 patients (27.6%). Low PEF was observed in 62 patients (64.5%), and low MEF25-75 was observed in 8 (8.3%). PFT was affected in 75 patients (78.1%). The pattern of involvement was restrictive. Age, height, and ferritin values significantly affected the MEF<sub>25-75</sub> (p<0.05). Age and pre-transfusion hemoglobin values had a significant effect on the FVC test (p<0.05). There was a weak negative correlation between ferritin values and MEF<sub>25-75</sub> (r=-0.221) and a weak positive correlation between pre-transfusion hemoglobin and FVC (r=0.222).</p><p><strong>Conclusion: </strong>Age and height are the main risk factors affecting FEV1, MEF<sub>25-75</sub>, and PEF. Serum ferritin has only an effect on MEF25-75 in our study. The respiratory functions of TM patients were affected in a restrictive pattern.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"589-596"},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/22/NCI-10-589.PMC10565749.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of mechanically ventilated children in pediatric intensive care unit: A single-center study. 儿科重症监护室机械通气儿童的临床特征:一项单中心研究。
Pub Date : 2023-09-13 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.90767
Cansu Durak, Kubra Boydag Guvenc

Objective: Mechanical ventilation (MV) remains the most challenging and important issue in the field of pediatrics. It is a life-saving, invasive procedure that supports the cardiovascular and respiratory systems until the underlying disease is cured. The aim of this study was to evaluate the demographic profile, clinical aspects, indications and complications of MV, and outcome of the children in the pediatric intensive care unit (PICU) of a tertiary hospital in a developing country.

Methods: The demographic profile, clinical aspects, MV indications and complications, and outcomes of pediatric patients (0-18 years of age) who required MV in the Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital PICU from February 2022 to January 2023 were retrospectively reviewed.

Results: A total of 139 patients were analyzed, of whom 79 (56.8%) were males. The median age was 36 months (1-214). Respiratory diseases (38.8%) were the most common indication for MV. We observed a 19.4% mortality rate with a statistically significant association with sepsis (p=0.001). Compared to other diseases, a large number of sepsis patients were found to require a variety of critical care treatment modalities and prolonged respiratory support.

Conclusion: Although MV is an indispensable treatment method in PICUs, it should not be forgotten that it carries the risk of morbidity and mortality in addition to the underlying disease. Therefore, the establishment of experienced teams in PICUs could make an important contribution to the prognosis of the patients.

目的:机械通气(MV)仍然是儿科领域最具挑战性和最重要的问题。这是一种拯救生命的侵入性手术,支持心血管和呼吸系统,直到潜在疾病治愈。本研究的目的是评估发展中国家一家三级医院儿科重症监护室(PICU)儿童的人口统计学特征、临床方面、MV的适应症和并发症以及预后。方法:回顾性分析2022年2月至2023年1月在Sancaktepe Sehit教授Ilhan Varank培训和研究医院PICU需要MV的儿科患者(0-18岁)的人口统计学特征、临床方面、MV适应症和并发症以及结果。结果:共分析139例患者,其中79例(56.8%)为男性。中位年龄为36个月(1-214)。呼吸系统疾病(38.8%)是MV最常见的适应症。我们观察到19.4%的死亡率与败血症有统计学意义(p=0.001)。与其他疾病相比,发现大量败血症患者需要多种重症监护治疗模式和长期呼吸支持。结论:尽管MV是PICU不可或缺的治疗方法,但不应忘记,除了潜在的疾病外,它还具有发病和死亡的风险。因此,在PICU中建立经验丰富的团队可以对患者的预后做出重要贡献。
{"title":"Clinical characteristics of mechanically ventilated children in pediatric intensive care unit: A single-center study.","authors":"Cansu Durak,&nbsp;Kubra Boydag Guvenc","doi":"10.14744/nci.2023.90767","DOIUrl":"10.14744/nci.2023.90767","url":null,"abstract":"<p><strong>Objective: </strong>Mechanical ventilation (MV) remains the most challenging and important issue in the field of pediatrics. It is a life-saving, invasive procedure that supports the cardiovascular and respiratory systems until the underlying disease is cured. The aim of this study was to evaluate the demographic profile, clinical aspects, indications and complications of MV, and outcome of the children in the pediatric intensive care unit (PICU) of a tertiary hospital in a developing country.</p><p><strong>Methods: </strong>The demographic profile, clinical aspects, MV indications and complications, and outcomes of pediatric patients (0-18 years of age) who required MV in the Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital PICU from February 2022 to January 2023 were retrospectively reviewed.</p><p><strong>Results: </strong>A total of 139 patients were analyzed, of whom 79 (56.8%) were males. The median age was 36 months (1-214). Respiratory diseases (38.8%) were the most common indication for MV. We observed a 19.4% mortality rate with a statistically significant association with sepsis (p=0.001). Compared to other diseases, a large number of sepsis patients were found to require a variety of critical care treatment modalities and prolonged respiratory support.</p><p><strong>Conclusion: </strong>Although MV is an indispensable treatment method in PICUs, it should not be forgotten that it carries the risk of morbidity and mortality in addition to the underlying disease. Therefore, the establishment of experienced teams in PICUs could make an important contribution to the prognosis of the patients.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"597-601"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/aa/NCI-10-597.PMC10565742.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Body fat percentage and infarct size in patients with non-ST segment elevation myocardial infarction. 非ST段抬高型心肌梗死患者的体脂百分比和梗死面积。
Pub Date : 2023-09-13 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.87259
Aylin Sungur, Mustafa Azmi Sungur, Baris Simsek, Ozan Tezen, Ahmet Cagdas Yumurtas, Duygu Inan, Duygu Genc, Fatma Can, Can Yucel Karabay

Objective: Obesity is a global health problem that increases the risk of coronary artery disease (CAD). However in studies, it has been observed that when the disease develops, obese patients have a more favorable prognosis than leaner patients. This is called the "obesity paradox." This study aims to evaluate the effect of obesity assessed with body fat percentage (BFP) and relative fat mass (RFM) besides body mass index (BMI) on infarct size (IS) estimated from peak creatine kinase-MB (CK-MB) levels in patients with non-ST-segment elevation myocardial infarction (NSTEMI).

Methods: Patients with a diagnosis of NSTEMI who underwent coronary angiography between January 2017 and January 2022 were retrospectively evaluated. Patients without available anthropometric data to calculate BMI, BFP, and RFM and serial CK-MB measurements were excluded from the study. BMI was calculated using weight(kg)/(height[m])2 formula. Patients were dichotomized as obese (BMI≥30 kg/m2) and non-obese (BMI<30 kg/m2) to compare baseline characteristics. BFP and RFM were calculated from anthropometric data. Linear regression analysis was performed to define predictors of IS.

Results: Final study population consisted of 748 NSTEMI patients (mean age was 59.3±11.2 years, 76.3% were men, 36.1% of the patients were obese). Obese patients were more likely to be female, hypertensive, and diabetic. Smoking was less frequently observed in obese patients. Peak CK-MB levels were similar among groups. Obese patients had higher in-hospital left ventricular ejection fraction, and less severe CAD was observed in coronary angiographies of these patients. Multivariable regression analysis identified diabetes mellitus, systolic blood pressure, white blood cell count, hemoglobin, and BFP (β=-4.8, 95% CI=-8.7; -0.3, p=0.03) as independent predictors of IS.

Conclusion: Higher BFP is associated with smaller IS in NSTEMI patients. These findings support the obesity paradox in this patient group, but further, randomized controlled studies are required.

目的:肥胖是一个全球性的健康问题,会增加患冠状动脉疾病(CAD)的风险。然而,在研究中,已经观察到,当疾病发展时,肥胖患者的预后比瘦患者更有利。这被称为“肥胖悖论”。本研究旨在评估肥胖对非ST段抬高型心肌梗死(NSTEMI)患者梗死面积(is)的影响,该影响是通过体脂百分比(BFP)和相对脂肪质量(RFM)以及体重指数(BMI)来评估的。方法:对2017年1月至2022年1月期间接受冠状动脉造影的诊断为NSTEMI的患者进行回顾性评估。没有可用的人体测量数据来计算BMI、BFP和RFM以及系列CK-MB测量的患者被排除在研究之外。使用体重(kg)/(身高[m])2公式计算BMI。将患者分为肥胖(BMI≥30 kg/m2)和非肥胖(BMI2),以比较基线特征。根据人体测量数据计算BFP和RFM。进行线性回归分析以确定IS的预测因素。结果:最终研究人群包括748名NSTEMI患者(平均年龄为59.3±11.2岁,76.3%为男性,36.1%为肥胖患者)。肥胖患者更可能是女性、高血压和糖尿病患者。肥胖患者吸烟的频率较低。各组间CK-MB峰值水平相似。肥胖患者住院时左心室射血分数较高,在这些患者的冠状动脉造影中观察到较轻的CAD。多变量回归分析确定糖尿病、收缩压、白细胞计数、血红蛋白和BFP(β=-4.8,95%CI=-8.7;-0.3,p=0.03)是IS的独立预测因素。结论:NSTEMI患者的BFP越高,IS越小。这些发现支持了这一患者群体的肥胖悖论,但还需要进一步的随机对照研究。
{"title":"Body fat percentage and infarct size in patients with non-ST segment elevation myocardial infarction.","authors":"Aylin Sungur,&nbsp;Mustafa Azmi Sungur,&nbsp;Baris Simsek,&nbsp;Ozan Tezen,&nbsp;Ahmet Cagdas Yumurtas,&nbsp;Duygu Inan,&nbsp;Duygu Genc,&nbsp;Fatma Can,&nbsp;Can Yucel Karabay","doi":"10.14744/nci.2023.87259","DOIUrl":"10.14744/nci.2023.87259","url":null,"abstract":"<p><strong>Objective: </strong>Obesity is a global health problem that increases the risk of coronary artery disease (CAD). However in studies, it has been observed that when the disease develops, obese patients have a more favorable prognosis than leaner patients. This is called the \"obesity paradox.\" This study aims to evaluate the effect of obesity assessed with body fat percentage (BFP) and relative fat mass (RFM) besides body mass index (BMI) on infarct size (IS) estimated from peak creatine kinase-MB (CK-MB) levels in patients with non-ST-segment elevation myocardial infarction (NSTEMI).</p><p><strong>Methods: </strong>Patients with a diagnosis of NSTEMI who underwent coronary angiography between January 2017 and January 2022 were retrospectively evaluated. Patients without available anthropometric data to calculate BMI, BFP, and RFM and serial CK-MB measurements were excluded from the study. BMI was calculated using weight(kg)/(height[m])<sup>2</sup> formula. Patients were dichotomized as obese (BMI≥30 kg/m<sup>2</sup>) and non-obese (BMI<30 kg/m<sup>2</sup>) to compare baseline characteristics. BFP and RFM were calculated from anthropometric data. Linear regression analysis was performed to define predictors of IS.</p><p><strong>Results: </strong>Final study population consisted of 748 NSTEMI patients (mean age was 59.3±11.2 years, 76.3% were men, 36.1% of the patients were obese). Obese patients were more likely to be female, hypertensive, and diabetic. Smoking was less frequently observed in obese patients. Peak CK-MB levels were similar among groups. Obese patients had higher in-hospital left ventricular ejection fraction, and less severe CAD was observed in coronary angiographies of these patients. Multivariable regression analysis identified diabetes mellitus, systolic blood pressure, white blood cell count, hemoglobin, and BFP (β=-4.8, 95% CI=-8.7; -0.3, p=0.03) as independent predictors of IS.</p><p><strong>Conclusion: </strong>Higher BFP is associated with smaller IS in NSTEMI patients. These findings support the obesity paradox in this patient group, but further, randomized controlled studies are required.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"567-574"},"PeriodicalIF":0.0,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/86/NCI-10-567.PMC10565745.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effects of general and spinal anesthesia for cesarean delivery on maternal and fetal outcomes: A retrospective analysis of data. 剖宫产全麻和腰麻对产妇和胎儿结局影响的比较:数据的回顾性分析。
Pub Date : 2023-09-11 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.25593
Mesure Gul Nihan Ozden, Senem Koruk, Zeynep Collak, Nur Panik

Objective: General or single-shut spinal anesthesia (SA) is applied for cesarean section and both methods of anesthesia have different effects on the mother and newborn. This retrospective study, in which 1-year data were analyzed, was aimed to examine the effects of general or SA on maternal and neonatal outcomes.

Methods: Anesthesia technique, mother's age, gestational age, number of pregnancies, previous cesarean delivery number, maternal complications, and indications for cesarean delivery were analyzed in 883 cesarean deliveries. In addition, weight and Apgar scores of newborn and umbilical cord blood gas values were examined.

Results: Neonatal intensive care need was higher in the general anesthesia (GA) group, Apgar scores were higher in the SA group, but neonatal mortality was similar. The umbilical cord Ph and lactate were lower; PCO2 values were higher in the GA group. Neonatal weight, mother's age, gestational age, and Apgar scores were predictive for neonatal mortality, but anesthesia technique was not.

Conclusion: While umbilical cord blood gas values were less affected and the need for neonatal intensive care was lower with SA, we believe that both anesthesia methods can be used safely for mother and neonatal in cesarean anesthesia considering maternal and neonatal morbidity and mortality.

目的:剖宫产手术采用全身或单次闭式脊麻(SA),两种麻醉方法对产妇和新生儿的影响不同。这项回顾性研究分析了一年的数据,旨在检验普通或SA对孕产妇和新生儿结局的影响。方法:对883例剖宫产患者的麻醉技术、母亲年龄、孕龄、妊娠次数、既往剖宫产次数、产妇并发症及剖宫产指征进行分析。此外,还检查了新生儿体重和Apgar评分以及脐带血气值。结果:全麻组新生儿重症监护需求较高,SA组Apgar评分较高,但新生儿死亡率相似。脐带Ph和乳酸盐含量较低;GA组的PCO2值较高。新生儿体重、母亲年龄、胎龄和Apgar评分可预测新生儿死亡率,但麻醉技术不能预测。结论:虽然SA对脐带血气值的影响较小,对新生儿重症监护的需求也较低,但考虑到产妇和新生儿的发病率和死亡率,我们相信这两种麻醉方法都可以安全地用于剖宫产麻醉中的母亲和新生儿。
{"title":"Comparison of the effects of general and spinal anesthesia for cesarean delivery on maternal and fetal outcomes: A retrospective analysis of data.","authors":"Mesure Gul Nihan Ozden,&nbsp;Senem Koruk,&nbsp;Zeynep Collak,&nbsp;Nur Panik","doi":"10.14744/nci.2023.25593","DOIUrl":"10.14744/nci.2023.25593","url":null,"abstract":"<p><strong>Objective: </strong>General or single-shut spinal anesthesia (SA) is applied for cesarean section and both methods of anesthesia have different effects on the mother and newborn. This retrospective study, in which 1-year data were analyzed, was aimed to examine the effects of general or SA on maternal and neonatal outcomes.</p><p><strong>Methods: </strong>Anesthesia technique, mother's age, gestational age, number of pregnancies, previous cesarean delivery number, maternal complications, and indications for cesarean delivery were analyzed in 883 cesarean deliveries. In addition, weight and Apgar scores of newborn and umbilical cord blood gas values were examined.</p><p><strong>Results: </strong>Neonatal intensive care need was higher in the general anesthesia (GA) group, Apgar scores were higher in the SA group, but neonatal mortality was similar. The umbilical cord Ph and lactate were lower; PCO<sub>2</sub> values were higher in the GA group. Neonatal weight, mother's age, gestational age, and Apgar scores were predictive for neonatal mortality, but anesthesia technique was not.</p><p><strong>Conclusion: </strong>While umbilical cord blood gas values were less affected and the need for neonatal intensive care was lower with SA, we believe that both anesthesia methods can be used safely for mother and neonatal in cesarean anesthesia considering maternal and neonatal morbidity and mortality.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"575-582"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/12/NCI-10-575.PMC10565739.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost analysis of 25-hydroxy vitamin D tests in Turkiye with big data: A cross-sectional study. 土耳其25种羟基维生素D测试的大数据成本分析:一项横断面研究。
Pub Date : 2023-08-29 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.42899
Mustafa Mahir Ulgu, Murat Caglayan, Naim Ata, Cigdem Sonmez, Mehmet Senes, Ozlem Gulbahar, Ataman Gonel, Suayip Birinci

Objective: The high prevalence of vitamin D deficiency in the population causes physicians to request more vitamin D tests and increases laboratory costs. It is aimed at investigating the demanded numbers and cost analyzes of 25-hydroxyvitamin D (25(OH)D) tests with the big data obtained from the national information health system of the Turkish Ministry of Health.

Methods: Between 2017 and 2018, all inpatient and outpatient tests and 25(OH)D tests in all medical biochemistry laboratories in Turkiye were determined based on department and institution type. The cost amount, distribution among health institutions, and test request rates were calculated. In both years, the top ten most expensive tests, according to health institutions, were evaluated.

Results: The total number of medical biochemistry tests performed in 2017 and 2018 was 1.424.948.155 and 1.713.134.326, respectively. The number of 25 (OH)D tests analyzed in the same years was 8.698.393 and 13.919.127, respectively. When the data of the 2 years are compared, the consumption of 25 (OH)D tests increased by 37% in General hospital laboratories, whereas it increased by 115.09% in primary health laboratories. When all health institutions were evaluated, the increase rate in 25 (OH)D test demand was 60%, while the cost increase rate was 23%.

Conclusion: This report showed that the demands for 25(OH)D testing are increasing steeply, especially in primary health-care facilities. In this direction, laboratory information system test demand restrictions in accordance with national and international guidelines are important issues for policymakers.

目的:人群中维生素D缺乏症的高患病率导致医生要求更多的维生素D检测,并增加了实验室费用。它旨在利用从土耳其卫生部国家信息卫生系统获得的大数据,调查25-羟基维生素D(25(OH)D)测试的需求数量和成本分析。方法:2017年至2018年间,根据科室和机构类型,确定土耳其所有医学生物化学实验室的所有住院和门诊测试以及25(OH)D测试。计算了费用金额、卫生机构之间的分布以及检测请求率。根据卫生机构的数据,在这两年中,对十大最昂贵的检测进行了评估。结果:2017年和2018年进行的医学生物化学测试总数分别为1.424.948.155和1.713.134.326。同一年分析的25次(OH)D测试次数分别为8.698.393次和13.919.127次。当比较2年的数据时,综合医院实验室的25(OH)D测试消耗增加了37%,而初级卫生实验室的消耗增加了115.09%。当对所有卫生机构进行评估时,25(OH)D检测需求的增长率为60%,而成本增长率为23%。结论:该报告显示,对25(OH)D检测的需求正在急剧增加,尤其是在初级保健机构。在这个方向上,根据国家和国际准则对实验室信息系统测试需求进行限制是决策者面临的重要问题。
{"title":"Cost analysis of 25-hydroxy vitamin D tests in Turkiye with big data: A cross-sectional study.","authors":"Mustafa Mahir Ulgu,&nbsp;Murat Caglayan,&nbsp;Naim Ata,&nbsp;Cigdem Sonmez,&nbsp;Mehmet Senes,&nbsp;Ozlem Gulbahar,&nbsp;Ataman Gonel,&nbsp;Suayip Birinci","doi":"10.14744/nci.2023.42899","DOIUrl":"10.14744/nci.2023.42899","url":null,"abstract":"<p><strong>Objective: </strong>The high prevalence of vitamin D deficiency in the population causes physicians to request more vitamin D tests and increases laboratory costs. It is aimed at investigating the demanded numbers and cost analyzes of 25-hydroxyvitamin D (25(OH)D) tests with the big data obtained from the national information health system of the Turkish Ministry of Health.</p><p><strong>Methods: </strong>Between 2017 and 2018, all inpatient and outpatient tests and 25(OH)D tests in all medical biochemistry laboratories in Turkiye were determined based on department and institution type. The cost amount, distribution among health institutions, and test request rates were calculated. In both years, the top ten most expensive tests, according to health institutions, were evaluated.</p><p><strong>Results: </strong>The total number of medical biochemistry tests performed in 2017 and 2018 was 1.424.948.155 and 1.713.134.326, respectively. The number of 25 (OH)D tests analyzed in the same years was 8.698.393 and 13.919.127, respectively. When the data of the 2 years are compared, the consumption of 25 (OH)D tests increased by 37% in General hospital laboratories, whereas it increased by 115.09% in primary health laboratories. When all health institutions were evaluated, the increase rate in 25 (OH)D test demand was 60%, while the cost increase rate was 23%.</p><p><strong>Conclusion: </strong>This report showed that the demands for 25(OH)D testing are increasing steeply, especially in primary health-care facilities. In this direction, laboratory information system test demand restrictions in accordance with national and international guidelines are important issues for policymakers.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"618-625"},"PeriodicalIF":0.0,"publicationDate":"2023-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/04/cc/NCI-10-618.PMC10565744.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertriglyceridemia and its impact on hematological indicators: A study based on Turkish national health database. 高甘油三酯血症及其对血液学指标的影响:基于土耳其国家健康数据库的研究。
Pub Date : 2023-08-28 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.71235
Suayip Birinci, Mustafa Mahir Ulgu, Murat Caglayan, Naim Ata

Objective: The hematocrit (Hct) to hemoglobin (Hb) ratio, generally at 3.0 in healthy individuals, can vary in certain disease states. An emerging area of interest is the potential influence of triglyceride concentrations on this ratio and hemoglobin A1C (HbA1c) levels. This study aimed to identify the changes in HbA1c and the Hct/Hb ratio as triglyceride concentration increases.

Methods: This research involved an extensive analysis of 35,656,613 laboratory samples taken between January 2015 and December 2022 in Türkiye, including the respective triglyceride, Hb, Hct, and HbA1c results. The laboratory test results were obtained from the national health database of the Turkish Ministry of Health. The triglyceride levels were divided into 24 groups, each incremented by 100 mg/dL from a range of 0-3099 mg/dL. Mean and standard deviation values of Hb and Hct were calculated for each group, and the Hct/Hb ratio was graphically represented.

Results: The average HbA1c values ranged between 4.37±0.85 and 7.76±3.19 across the groups, Hb averages ranged from 9.75±1.7 to 14.03±2.21, Hct averages from 27.35±4.97 to 38.86±5.66, and Hct/Hb ratios varied between 2.77 and 3.03. The overall average for all samples was identified as 5.15±0.13 for HbA1c, 38.48±5.13 for Hct, 12.73±1.65 for Hb, and 3.02 for the Hct/Hb ratio.

Conclusion: It was observed that the Hct/Hb ratio gradually decreased as triglyceride levels increased. Evaluating anemia based on Hb concentration in individuals with hypertriglyceridemia might be misleading. It is recommended to use a correction factor based on triglyceride level.

目的:健康人的红细胞压积(Hct)与血红蛋白(Hb)的比值通常为3.0,在某些疾病状态下可能会有所不同。一个新出现的感兴趣的领域是甘油三酯浓度对该比率和血红蛋白A1C(HbA1c)水平的潜在影响。本研究旨在确定随着甘油三酯浓度的增加,HbA1c和Hct/Hb比率的变化。方法:本研究对2015年1月至2022年12月期间在土耳其采集的35656613份实验室样本进行了广泛分析,包括甘油三酯、Hb、Hct和HbA1c的结果。实验室检测结果来自土耳其卫生部的国家卫生数据库。甘油三酯水平被分为24组,每组从0-3099 mg/dL的范围增加100 mg/dL。计算各组Hb和Hct的平均值和标准偏差值,并用图形表示Hct/Hb比率。结果:各组的平均HbA1c值在4.37±0.85和7.76±3.19之间,Hb平均值在9.75±1.7到14.03±2.21之间,Hct平均值在27.35±4.97到38.86±5.66之间,Hct/Hb比值在2.77到3.03之间。所有样本的总平均值HbA1c为5.15±0.13,Hct为38.48±5.13,Hb为12.73±1.65,Hct/Hb比率为3.02。结论:Hct/Hb比值随甘油三酯水平的升高而逐渐降低。根据高甘油三酯血症患者的Hb浓度来评估贫血可能会产生误导。建议使用基于甘油三酯水平的校正系数。
{"title":"Hypertriglyceridemia and its impact on hematological indicators: A study based on Turkish national health database.","authors":"Suayip Birinci,&nbsp;Mustafa Mahir Ulgu,&nbsp;Murat Caglayan,&nbsp;Naim Ata","doi":"10.14744/nci.2023.71235","DOIUrl":"10.14744/nci.2023.71235","url":null,"abstract":"<p><strong>Objective: </strong>The hematocrit (Hct) to hemoglobin (Hb) ratio, generally at 3.0 in healthy individuals, can vary in certain disease states. An emerging area of interest is the potential influence of triglyceride concentrations on this ratio and hemoglobin A1C (HbA1c) levels. This study aimed to identify the changes in HbA1c and the Hct/Hb ratio as triglyceride concentration increases.</p><p><strong>Methods: </strong>This research involved an extensive analysis of 35,656,613 laboratory samples taken between January 2015 and December 2022 in Türkiye, including the respective triglyceride, Hb, Hct, and HbA1c results. The laboratory test results were obtained from the national health database of the Turkish Ministry of Health. The triglyceride levels were divided into 24 groups, each incremented by 100 mg/dL from a range of 0-3099 mg/dL. Mean and standard deviation values of Hb and Hct were calculated for each group, and the Hct/Hb ratio was graphically represented.</p><p><strong>Results: </strong>The average HbA1c values ranged between 4.37±0.85 and 7.76±3.19 across the groups, Hb averages ranged from 9.75±1.7 to 14.03±2.21, Hct averages from 27.35±4.97 to 38.86±5.66, and Hct/Hb ratios varied between 2.77 and 3.03. The overall average for all samples was identified as 5.15±0.13 for HbA1c, 38.48±5.13 for Hct, 12.73±1.65 for Hb, and 3.02 for the Hct/Hb ratio.</p><p><strong>Conclusion: </strong>It was observed that the Hct/Hb ratio gradually decreased as triglyceride levels increased. Evaluating anemia based on Hb concentration in individuals with hypertriglyceridemia might be misleading. It is recommended to use a correction factor based on triglyceride level.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"626-630"},"PeriodicalIF":0.0,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/55/NCI-10-626.PMC10565748.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ber-EP4 staining patterns on basal cell carcinomas. 基底细胞癌的Ber-EP4染色模式。
Pub Date : 2023-08-27 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2022.25675
Seyma Ozkanli

Objective: This article aimed to study two different parameters of basal cell carcinoma (BCC): First, to analyze the expression of antihuman epithelial antigen (Ber-EP4) on the primary and recurrent BCCs on the head, neck, and other body parts and second, to find Ber-EP4's staining pattern and staining intensities correlation between histological type, demographic data, tumor, and its prognostic parameters.

Methods: We evaluated the Ber-EP4 staining patterns of 201 patients diagnosed with BCC. We analyzed the possible correlation between the tumor's prognostic parameters and the Ber-EP4 staining intensity and its pattern (peripheral, superficial, or diffused).

Results: In 199 out of the 201 cases, staining was observed. Two cases were unstained. In 25.6% (n=51) of the cases with staining, the staining was weak, on the 25.6% (n=51), it was moderate, and on the 48.8% (n=97), it was severe. The staining pattern was 31.2% (n=62) peripheral, 4.0% (n=8) superficial, 54.7% (n=109) diffuse, and 10.1% (n=20) peripheral and superficial.

Conclusion: Ber-EP4 is the only antibody commonly used for BCC diagnosis; the existence of different staining intensities and patterns in BCC tumor cells in routine dermatopathology practice limit the pathologists. The studies investigating Ber-EP4 staining in BCCs were conducted with very small numbers of cases. In these studies, even the presence of staining in the focal area was considered to be a positive acceptance criterion; the staining intensity and pattern were not evaluated. Therefore, our study is the first study with a high number of cases and the first to include an evaluation of Ber-EP4 staining's intensity and localization.

目的:本文旨在研究基底细胞癌(BCC)的两个不同参数:首先,分析抗人上皮抗原(Ber-EP4)在头部、颈部和其他身体部位的原发性和复发性基底细胞癌上的表达,及其预后参数。方法:我们对201例BCC患者的Ber-EP4染色模式进行了评估。我们分析了肿瘤的预后参数与Ber-EP4染色强度及其模式(外周、浅表或扩散)之间的可能相关性。有两例未染色。在25.6%(n=51)的染色病例中,染色较弱,25.6%(n=51)为中度,48.8%(n=97)为重度。染色模式为31.2%(n=62)外周,4.0%(n=8)浅表,54.7%(n=109)弥漫,10.1%(n=20)外周和浅表。结论:Ber-EP4是唯一常用于BCC诊断的抗体;在常规皮肤病理学实践中BCC肿瘤细胞中存在不同的染色强度和模式限制了病理学家。研究BCCs中Ber-EP4染色的研究是在极少数病例中进行的。在这些研究中,即使在病灶区域存在染色也被认为是一个积极的接受标准;未评估染色强度和模式。因此,我们的研究是第一个有大量病例的研究,也是第一个包括Ber-EP4染色强度和定位评估的研究。
{"title":"Ber-EP4 staining patterns on basal cell carcinomas.","authors":"Seyma Ozkanli","doi":"10.14744/nci.2022.25675","DOIUrl":"10.14744/nci.2022.25675","url":null,"abstract":"<p><strong>Objective: </strong>This article aimed to study two different parameters of basal cell carcinoma (BCC): First, to analyze the expression of antihuman epithelial antigen (Ber-EP4) on the primary and recurrent BCCs on the head, neck, and other body parts and second, to find Ber-EP4's staining pattern and staining intensities correlation between histological type, demographic data, tumor, and its prognostic parameters.</p><p><strong>Methods: </strong>We evaluated the Ber-EP4 staining patterns of 201 patients diagnosed with BCC. We analyzed the possible correlation between the tumor's prognostic parameters and the Ber-EP4 staining intensity and its pattern (peripheral, superficial, or diffused).</p><p><strong>Results: </strong>In 199 out of the 201 cases, staining was observed. Two cases were unstained. In 25.6% (n=51) of the cases with staining, the staining was weak, on the 25.6% (n=51), it was moderate, and on the 48.8% (n=97), it was severe. The staining pattern was 31.2% (n=62) peripheral, 4.0% (n=8) superficial, 54.7% (n=109) diffuse, and 10.1% (n=20) peripheral and superficial.</p><p><strong>Conclusion: </strong>Ber-EP4 is the only antibody commonly used for BCC diagnosis; the existence of different staining intensities and patterns in BCC tumor cells in routine dermatopathology practice limit the pathologists. The studies investigating Ber-EP4 staining in BCCs were conducted with very small numbers of cases. In these studies, even the presence of staining in the focal area was considered to be a positive acceptance criterion; the staining intensity and pattern were not evaluated. Therefore, our study is the first study with a high number of cases and the first to include an evaluation of Ber-EP4 staining's intensity and localization.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"666-674"},"PeriodicalIF":0.0,"publicationDate":"2023-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/e5/NCI-10-666.PMC10565738.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of cardiac adverse effects in COVID-19 ARDS patients treated with intravenous immunoglobulin. 静脉注射免疫球蛋白治疗新冠肺炎ARDS患者的心脏不良反应调查。
Pub Date : 2023-08-26 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.50336
Ayse Ayyildiz, Ozge Turgay Yildirim, Anil Ucan, Fatih Alper Ayyildiz, Fezan Mutlu

Objective: The popularity of intravenous immunoglobulin (IVIG) therapy in Acute Respiratory Distress Syndrome (CARDS) secondary to COVID-19 infection is increasing day by day. In this study, we aimed to retrospectively evaluate the possible cardiac effects in our CARDS patients treated with IVIG.

Methods: Demographic and clinical characteristics, mortality, sequential electrocardiography (ECG), echocardiography, cardiac markers, and other laboratory parameters of CARDS patients who received IVIG treatment were recorded.

Results: The mean age of the patients was 68.7±13.6%, and 70.5% were female. The mean number of days of hospitalization in the intensive care unit was 18.2±9.7, and the mortality rate was recorded as 35.2%. No pathological rhythm or ischemic change was observed in sequential ECG follow-ups. However, in consecutive ECO follow-ups, the sPAP values at the treatment end were numerically lower, although not statistically significant.

Conclusion: Our study suggests that IVIG therapy may be used safely in COVID-19 patients with cardiovascular side effects. However, due to the high risk of coagulopathy in these patients, the use of IVIG therapy in COVID-19 infection should be monitored with close monitoring, as it may increase the potential for cardiovascular risk. Furthermore, monitoring cardiac parameters are also essential as it may predict high cardiovascular risk in patients. For this reason, patients need lower infusion rates, steroid combination, adequate hydration, and effective anticoagulation therapy to avoid these side effects.

目的:静脉注射免疫球蛋白(IVIG)治疗新冠肺炎感染后急性呼吸窘迫综合征(CARDS)日益流行。在本研究中,我们旨在回顾性评估接受IVIG治疗的CARDS患者可能的心脏影响。方法:记录接受IVIG处理的CARDS病人的人口学和临床特征、死亡率、心电图、超声心动图、心脏标志物和其他实验室参数。结果:患者平均年龄为68.7±13.6%,女性占70.5%。重症监护室的平均住院天数为18.2±9.7天,死亡率为35.2%。在连续的心电图随访中没有观察到病理节律或缺血性变化。然而,在连续的ECO随访中,治疗结束时的sPAP值在数值上较低,尽管没有统计学意义。结论:我们的研究表明,IVIG治疗可能安全地用于有心血管副作用的新冠肺炎患者。然而,由于这些患者凝血障碍的风险很高,应密切监测IVIG治疗新冠肺炎感染的使用情况,因为这可能会增加心血管风险。此外,监测心脏参数也很重要,因为它可以预测患者的高心血管风险。因此,患者需要较低的输注率、类固醇组合、充足的水合作用和有效的抗凝治疗来避免这些副作用。
{"title":"Investigation of cardiac adverse effects in COVID-19 ARDS patients treated with intravenous immunoglobulin.","authors":"Ayse Ayyildiz,&nbsp;Ozge Turgay Yildirim,&nbsp;Anil Ucan,&nbsp;Fatih Alper Ayyildiz,&nbsp;Fezan Mutlu","doi":"10.14744/nci.2023.50336","DOIUrl":"10.14744/nci.2023.50336","url":null,"abstract":"<p><strong>Objective: </strong>The popularity of intravenous immunoglobulin (IVIG) therapy in Acute Respiratory Distress Syndrome (CARDS) secondary to COVID-19 infection is increasing day by day. In this study, we aimed to retrospectively evaluate the possible cardiac effects in our CARDS patients treated with IVIG.</p><p><strong>Methods: </strong>Demographic and clinical characteristics, mortality, sequential electrocardiography (ECG), echocardiography, cardiac markers, and other laboratory parameters of CARDS patients who received IVIG treatment were recorded.</p><p><strong>Results: </strong>The mean age of the patients was 68.7±13.6%, and 70.5% were female. The mean number of days of hospitalization in the intensive care unit was 18.2±9.7, and the mortality rate was recorded as 35.2%. No pathological rhythm or ischemic change was observed in sequential ECG follow-ups. However, in consecutive ECO follow-ups, the sPAP values at the treatment end were numerically lower, although not statistically significant.</p><p><strong>Conclusion: </strong>Our study suggests that IVIG therapy may be used safely in COVID-19 patients with cardiovascular side effects. However, due to the high risk of coagulopathy in these patients, the use of IVIG therapy in COVID-19 infection should be monitored with close monitoring, as it may increase the potential for cardiovascular risk. Furthermore, monitoring cardiac parameters are also essential as it may predict high cardiovascular risk in patients. For this reason, patients need lower infusion rates, steroid combination, adequate hydration, and effective anticoagulation therapy to avoid these side effects.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"560-566"},"PeriodicalIF":0.0,"publicationDate":"2023-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/64/c9/NCI-10-560.PMC10565752.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous leishmaniasis of the eyelids: Retrospective evaluation of 18 patients. 眼睑皮肤利什曼病:18例患者的回顾性评价。
Pub Date : 2023-08-25 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2023.71205
Armagan Ozgur, Isa An

Objective: Although eyelid involvement is rare in cutaneous leishmaniasis (CL), it can cause severe ocular complications if the diagnosis is delayed and not treated. Our purpose in this study is to examine the clinical characteristics, diagnosis, and treatment methods as well as accompanying ocular complications in patients with CL diagnosis and eyelid involvement.

Methods: In this retrospective study, the clinical characteristics, diagnosis, and treatment methods of the disease as well as accompanying ocular complications were examined for 18 patients with CL diagnosis and eyelid involvement between May 2018 and October 2022 in our Dermatology and venereal diseases clinic.

Results: 10 (55%) of the patients were male and 8 (45%) were female. Unilateral lower eyelid involvement was most common (9 patients [50%]). Chalazion-like lesions (8 patients [45%]) were observed most commonly. All patients were diagnosed with CL by direct microscopic examination and were given systemic meglumine antimonate treatment. No ocular complications were observed in any of the patients.

Conclusion: It should be kept in mind that eyelid involvement may occur in CL, and ophthalmological examinations of these cases should be performed and treatment should be initiated in the early period to prevent possible ocular complications.

目的:尽管眼睑受累在皮肤利什曼病(CL)中很少见,但如果诊断延迟且不治疗,可能会导致严重的眼部并发症。我们在本研究中的目的是检查CL诊断和眼睑受累患者的临床特征、诊断和治疗方法以及伴随的眼部并发症。方法:在这项回顾性研究中,我们对2018年5月至2022年10月在我们的皮肤性病诊所诊断为CL并累及眼睑的18名患者的临床特征、诊断、治疗方法以及伴随的眼部并发症进行了检查。结果:男性10例(55%),女性8例(45%)。单侧下眼睑受累最为常见(9例[50%])。Chalazion样病变(8例[45%])最常见。所有患者均通过直接显微镜检查诊断为CL,并给予全身锑酸葡胺治疗。未观察到任何患者出现眼部并发症。结论:CL可能发生眼睑受累,应注意对这些病例进行眼科检查,并在早期开始治疗,以防止可能的眼部并发症。
{"title":"Cutaneous leishmaniasis of the eyelids: Retrospective evaluation of 18 patients.","authors":"Armagan Ozgur,&nbsp;Isa An","doi":"10.14744/nci.2023.71205","DOIUrl":"10.14744/nci.2023.71205","url":null,"abstract":"<p><strong>Objective: </strong>Although eyelid involvement is rare in cutaneous leishmaniasis (CL), it can cause severe ocular complications if the diagnosis is delayed and not treated. Our purpose in this study is to examine the clinical characteristics, diagnosis, and treatment methods as well as accompanying ocular complications in patients with CL diagnosis and eyelid involvement.</p><p><strong>Methods: </strong>In this retrospective study, the clinical characteristics, diagnosis, and treatment methods of the disease as well as accompanying ocular complications were examined for 18 patients with CL diagnosis and eyelid involvement between May 2018 and October 2022 in our Dermatology and venereal diseases clinic.</p><p><strong>Results: </strong>10 (55%) of the patients were male and 8 (45%) were female. Unilateral lower eyelid involvement was most common (9 patients [50%]). Chalazion-like lesions (8 patients [45%]) were observed most commonly. All patients were diagnosed with CL by direct microscopic examination and were given systemic meglumine antimonate treatment. No ocular complications were observed in any of the patients.</p><p><strong>Conclusion: </strong>It should be kept in mind that eyelid involvement may occur in CL, and ophthalmological examinations of these cases should be performed and treatment should be initiated in the early period to prevent possible ocular complications.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"651-656"},"PeriodicalIF":0.0,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/cd/NCI-10-651.PMC10565750.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the triggers and the treatment models of anaphylaxis in pediatric patients. 儿科患者过敏反应的触发因素和治疗模型的评估。
Pub Date : 2023-08-25 eCollection Date: 2023-01-01 DOI: 10.14744/nci.2022.68335
Sevgi Sipahi Cimen, Ayse Suleyman, Esra Yucel, Nermin Guler, Zeynep Tamay

Objective: Anaphylaxis is an acute, life-threatening systemic hypersensitivity reaction. We aimed to evaluate the demographic and clinical characteristics of patients presenting with anaphylaxis, as well as triggers and risk factors, and to determine the rate of adrenaline auto-injector (AAI) usage.

Methods: The study was planned in the pediatric allergy outpatient clinic over a 1-year period. The data of children diagnosed with anaphylaxis were evaluated retrospectively; demographic characteristics, causes of anaphylaxis, and treatment modalities were recorded in the created study form.

Results: Eighty children (29 females) with a median age of 6.5 years (range: 1 month-17 years) were evaluated. The most common triggers were foods under 2 years of age (73%), and drugs (70%) above 2 years of age. Nearly half of the anaphylaxis episodes (n=41, 51.3%) occurred at home. Cutaneous and respiratory symptoms were the most commonly reported complaints (98.8%). The median age of the patients at the first attack with severe anaphylaxis (n=29, 36.3%) was significantly higher than the rest (p:0.007). The age at onset of the reaction (p:0.006) and occurrence of the reaction in hospital conditions (p<0.001) were determined to be significant risk factors for severe anaphylaxis. Most of them received antihistamines (95.7%) and corticosteroids (91.3%), while 78.3% received adrenaline. Only 9.5% of patients with recurrent episodes of anaphylaxis used AAIs.

Conclusion: Foods in infants and drugs in older children were the leading causative allergens of anaphylaxis. The most common clinical manifestations were respiratory and cutaneous symptoms. The older age at onset of the reaction and the occurrence of the reaction in hospital conditions were determined to be significant risk factors for severe anaphylaxis. It was determined that the frequency of AAI use was low among patients and their families.

目的:过敏反应是一种急性、危及生命的全身超敏反应。我们旨在评估过敏反应患者的人口统计学和临床特征,以及触发因素和风险因素,并确定肾上腺素自动注射器(AAI)的使用率。方法:本研究计划在儿科过敏门诊进行,为期1年。对诊断为过敏反应的儿童的资料进行回顾性评价;在创建的研究表格中记录了人口统计学特征、过敏反应的原因和治疗方式。结果:对80名中位年龄为6.5岁(范围:1个月至17岁)的儿童(29名女性)进行了评估。最常见的诱因是2岁以下的食物(73%)和2岁以上的药物(70%)。近一半的过敏反应(n=41,51.3%)发生在家中。皮肤和呼吸道症状是最常见的主诉(98.8%)。首次出现严重过敏反应的患者的中位年龄(n=29,36.3%)明显高于其他患者(p:0.007)。出现反应的年龄(p:0.006)和在医院条件下发生反应(结论:婴儿食物和儿童药物是引起过敏反应的主要过敏原。最常见的临床表现是呼吸道和皮肤症状。反应发生时年龄较大和在医院条件下发生反应被确定为严重过敏反应的重要危险因素f AAI在患者及其家属中的使用率较低。
{"title":"Evaluation of the triggers and the treatment models of anaphylaxis in pediatric patients.","authors":"Sevgi Sipahi Cimen,&nbsp;Ayse Suleyman,&nbsp;Esra Yucel,&nbsp;Nermin Guler,&nbsp;Zeynep Tamay","doi":"10.14744/nci.2022.68335","DOIUrl":"10.14744/nci.2022.68335","url":null,"abstract":"<p><strong>Objective: </strong>Anaphylaxis is an acute, life-threatening systemic hypersensitivity reaction. We aimed to evaluate the demographic and clinical characteristics of patients presenting with anaphylaxis, as well as triggers and risk factors, and to determine the rate of adrenaline auto-injector (AAI) usage.</p><p><strong>Methods: </strong>The study was planned in the pediatric allergy outpatient clinic over a 1-year period. The data of children diagnosed with anaphylaxis were evaluated retrospectively; demographic characteristics, causes of anaphylaxis, and treatment modalities were recorded in the created study form.</p><p><strong>Results: </strong>Eighty children (29 females) with a median age of 6.5 years (range: 1 month-17 years) were evaluated. The most common triggers were foods under 2 years of age (73%), and drugs (70%) above 2 years of age. Nearly half of the anaphylaxis episodes (n=41, 51.3%) occurred at home. Cutaneous and respiratory symptoms were the most commonly reported complaints (98.8%). The median age of the patients at the first attack with severe anaphylaxis (n=29, 36.3%) was significantly higher than the rest (p:0.007). The age at onset of the reaction (p:0.006) and occurrence of the reaction in hospital conditions (p<0.001) were determined to be significant risk factors for severe anaphylaxis. Most of them received antihistamines (95.7%) and corticosteroids (91.3%), while 78.3% received adrenaline. Only 9.5% of patients with recurrent episodes of anaphylaxis used AAIs.</p><p><strong>Conclusion: </strong>Foods in infants and drugs in older children were the leading causative allergens of anaphylaxis. The most common clinical manifestations were respiratory and cutaneous symptoms. The older age at onset of the reaction and the occurrence of the reaction in hospital conditions were determined to be significant risk factors for severe anaphylaxis. It was determined that the frequency of AAI use was low among patients and their families.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"10 5","pages":"609-617"},"PeriodicalIF":0.0,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/7f/NCI-10-609.PMC10565756.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Northern clinics of Istanbul
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1